[1] 程抗, 张晓菲, 宋蔚. 免疫抑制剂临床应用新进展[J]. 中国医药导刊, 2008, 10(8): 1204-1205. [2] 潘春树,何雪菲, 钱华. 常用免疫抑制剂的作用机制及应用[J].安徽医药, 2008, 12(10) : 892-894. [3] 夏东亚, 郭涛, 蒋苓, 等. ELISA法监测肝移植患者他克莫司全血浓度[J].中国临床药理学与治疗学,2006, 11(8): 933-936. [4] 邹德琴, 王小中, 魏筱华,等. MEIA法测定他克莫司全血浓度的问题分析[J]. 实用临床医学, 2008, 9(10): 16-17. [5] 叶伟民, 陆慧琦, 朱烨, 等. 他克莫司在临床检测中的方法学比较[J].现代检验医学杂志, 2008, 23(2): 85-87. [6] 丁春雷, 刘丽宏, 马萍, 等. 他克莫司治疗药物监测研究进展[J].中国药房, 2008, 19(20): 1580-1582. [7] 李鹏飞, 刘丽宏, 马 萍, 等. 高效液相色谱-串联质谱法在他克莫司临床血药浓度监测中的应用[J]. 质谱学报, 2008, 29(3): 137-143. [8] Chena YL, Hirabayashi H, Akhtar S, et al. Simultaneous determination of three isomeric metabolites of tacrolimus(FK506) in human whole blood and plasma using high performance liquid chromatography-tandem mass spectrometry[J]. J Chromatogr B Anslyt Technol Biomed Life Sci,2006,830(2): 330-341. [9] 丁慧, 董振南, 贾兴旺, 等.他克莫司血药浓度的方法学评价[J]. 标记免疫分析与临床, 2010,17(4):264-265. [10] 梁陈方, 王亚洲.反相高效液相色谱法测定他克莫司的血药浓度[J]. 广西医学,2009, 31(3): 425-426. [11] 刘文豹, 刘增, 牛德森, 等. 环孢素A血药浓度监测方法比较分析[J]. 标记免疫分析与临床, 2006, 13(3):188. [12] 宋丽丽, 陈东生, 吕永宁. 环孢素血药浓度监测方法比较[J]. 医药导报,2008,27(2):210-212. [13] 戴志凌, 帅莉, 苏琴. 单克隆荧光偏振免疫法和高效液相色谱法测定环孢素A全血浓度的相关性[J]. 药物研究, 2008, 17 (21): 16-18. [14] McBride JH,Kim S,Rodgerson DO,et al.Conversion of cardiac and liver transplant recipients from HPLC and FPIA (polyclona1)to an FPIA(monoclona1) technique for measurement of blood cyclosporin A[J].J Clin Lab Anal,1998,12(6): 337-340. [15] 章秀兰, 顾志冬, 施新明, 等. 高效毛细管电泳法检测血中环孢素A浓度[J].诊断学理论与实践, 2004, 3(4): 280-286. [16] 刘晓, 李凯鹏, 李朋梅, 等. 反相高效液相紫外法测定人全血中环孢素A含量[J].中日友好医院学报, 2008, 22(5): 307-308. [17] 赵驻军, 张翠欣, 李亚, 等. 高效液相色谱法检测人全血环孢素A浓度[J]. 河北医药, 2006, 28(10): 995-996. [18] Zaater MF,Tahboub YR,Najib NM.Liquid chromatographic-electrospray mass spectrometric determination of cyclosporin A in human plasma[J]. Anal Bioanal Chem, 2005, 382(1): 223-230. [19] Vollenbroeker B, Koch JH, Fobker M, et al. Determination of cyclosporine and its metabolites in blood via HPLC-MS and correlation to clinically important parameters[J]. Transplant Proc, 2005, 37(4): 1741-1744. [20] Wang GF, Hsieh Y, Korfmacher WA. Comparison of atmospheric pressure chemical ionization, electrospray ionization, and atmospheric pressure photoionization for the determination of cyclosporin A in rat plasma[J]. Anal Chem, 2005, 77(2): 541-548. [21] Roberts NB, Dutton J, Higgins G, et al. Evaluation of a novel semi-automated HPLC procedure for whole blood cyclosporin A confirms equivalence to adjusted monoclonal values from Abbott TD[J]. Clin Chem Lab Med, 2005, 43(2): 228-236. [22] Hatsis P, Volmer DA.Evaluation of a cyano stationary phase for the determination of tacrolimus, sirolimus and cyclosporin A in whole blood by high-performance liquid chromatography-tandem mass spectrometry[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2004, 809(2): 287-294. [23] Poquette MA, Lensmeyer GL, Doran TC. Effective use of liquid chromatography-mass spectrometry(LC/MS) in the routine clinical laboratory for monitoring sirolimus, tacrolimus, and cyclosporine[J]. Ther Drug Monit, 2005, 27(2): 144-150. [24] Small DS, Acheampong A, Reis B, et al. Blood concentrations of cyclosporin a during long-term treatment with cyclosporin a ophthalmic emulsions in patients with moderate to severe dry eye disease[J].J Ocul Pharmacol Ther,2002, 18(5):411-418. [25] 王淑民, 李鹏飞, 赵秀丽,等. LC-MS/MS法测定人全血中环孢素A浓度及环孢素眼用乳剂健康人体药代动力学研究[J]. 质谱学报, 2010, 31(1): 53-58. [26] 任斌, 李敏薇, 唐蕾, 等.高效液相色谱法快速测定霉酚酸血药浓度[J]. 中国医院药学杂志, 2008, 28(5): 407-408. [27] 师少军, 李忠芳, 万元胜, 等. HPLC法测定人血浆中霉酚酸的浓度及药动学研究[J]. 中国药房, 2007, 18(20): 1558-1560. [28] 叶丽卡, 谢志红, 王若伦, 等. HPLC法测定肾移植患者血浆中霉酚酸的浓度[J].中国药房, 2008, 19(17): 1306-1308. [29] 南峰, 余勤, 梁茂植, 等. RP-HPLC法测定肾移植病人血浆中霉酚酸浓度及其应用[J]. 药物分析杂志, 2004, 24(3): 275-278. [30] 王晓红, 杨淑敏. 高效液相色谱法测定患者血浆中霉酚酸浓度[J].中国冶金工业医学杂志, 2008, 25(5): 531-532. [31] 胡咏华, 裴奇. 高效液相色谱法测定人血浆中霉酚酸的浓度[J]. 中南药学, 2009, 7(2): 317-319. [32] 郑国钢, 郑怀宇, 郑金琪, 等. 高效液相色谱-质谱联用法测定人血浆中霉酚酸的浓度[J].中国医院药学杂志, 2008, 28(7): 522-525. [33] 罗志刚, 唐孝达, 邓显昭, 等. 内源性糖皮质激素浓度测定在肾移植中的意义[J]. 华西医学, 1997, 12(1): 107-109. [34] 夏运成, 张旭光, 李江, 等. HPLC法测定强的松的血药浓度及其临床应用价值[J]. 医学临床研究, 2006, 23(8): 1213-1216. [35] Ionita IA, Fast DM, Akhlaghi F, et al.Development of a sensitive and selective method for the quantitative analysis of cortisol, cortisone, prednisolone and prednisone in human plasma[J]. J Chromatogra B Analyt Technol Biomed Life Sci,2009, 877 (8/9): 765-772. [36] Shibasaki H , Nakayama H, Furuta T, et al. Simultaneous determination of prednisolone, prednisone, cortisol, and cortisone in plasma by GC-MS: Estimating unbound prednisolone concentration in patients with nephrotic syndrome during oral prednisolone therapy[J]. J Chromatogr B Analyt Technol Biomed Life Sci ,2008,870 (2): 164-169. [37] 董振南, 贾兴旺, 王玲, 等. 微粒子酶联免疫吸附法测定西罗莫司血药浓度的方法学评价[J]. 军医进修学院学报, 2006, 27(5): 366-367. [38] 李月霞, 张弋, 付鹏. 肾移植1例的西罗莫司全血浓度监测[J].临床和实验医学杂志, 2010, 9(7): 554-555. [39] 李敏薇, 任斌, 张志豪, 等.高效液相色谱法快速测定西罗莫司血药浓度[J].中国医院药学杂志[J] , 2008, 28(9): 760-761. [40] 黎曙霞, 任斌, 王长希, 等.固相萃取-HPLC法测定西罗莫司的血药浓度及其临床应用研究[J].中国药房, 2008, 19(20): 1540-1542. [41] 张东娣, 范艳花. 液-质联用在西罗莫司和依维莫司血药浓度监测中的应用进展[J].商丘师范学院学报, 2007, 23(12): 90-93. [42] 祝仕清, 牛长群, 耿亚鹏. UPLC(超高效液相色谱)/MS /MS联用技术测定全血中的西罗莫司[J].中国抗生素杂志, 2007, 32(6): 347-349. [43] Difrancesco R, Frerichs V, Donnelly J, et al.Simultaneous determination of cortisol, dexamethasone, methylprednisolone, prednisone, prednisolone, mycophenolicacid and mycophenolic acid glucuronide in human plasma utilizing liquid chromatography-tandem mass spectrometry[J].J Chromatogr B Analyt Technol Biomed Life Sci,2007,859(1):42-51. [44] Bogusz MJ, Enazi EA, Hassan H, et al. Simultaneous LC-MS-MS determination of cyclosporine A, tacrolimus, and sirolimus in whole blood as well as mycophenolic acid in plasma using common pretreatment procedure[J].J Chromatogr B Analyt Technol Biomed Life Sci, 2007, 850(1/2): 471-480. [45] Ansermot N, Fathi M, Veuthey JL, et al. Simultaneous quantification of cyclosporine, tacrolimus, sirolimus and everolimus in whole blood by liquid chromatography-electrospraymass spectrometry[J].Clin Biochem,2008,41(9):728-735. [46] Op den Buijsch RA, Christiaans MH, Stolk LM, et al.Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1(ABCB1) and cytochrome (CYP)3A polymorphisms[J]. Fundam Clin Pharmacol, 2007, 21(4):427-435. [47] Macphee IA, Fredericks S, Tai T,et al.The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation[J]. Am J Transplant, 2004, 4(6): 914-919. [48] Poquette MA, Lensmeyer GL, Doran TC. Effective use of liquid chromatography-mass spectrometry (LC/MS) in the routine clinical laboratory for monitoring sirolimus, tacrolimus, and cyclosporine[J]. Ther Drug Monit,2005, 27(2): 144-150. [49] Hatsis P, Volmer DA. Evaluation of a cyano stationary phase for the determination of tacrolimus, sirolimus and cyclosporin A in whole blood by high-performance liquid chromatography-tandem mass spectrometry[J]. J Chromatogr B Analyt Technol Biomed Life Sci,2004, 809(2): 287-294. [50] Streit F, Armstrong VW, Oellerich M.Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood[J].Clin Chem,2002, 48(6 pt 1): 955-958. [51] Deters M, Kirchner G, Resch K, et al. Simultaneous quantification of sirolimus, everolimus, tacrolimus and cyclosporine by liquid chromatography-mass spectrometry (LC-MS) [J].Clin Chem Lab Med,2002, 40(3): 285-295. [52] Taylor PJ, Salm P, Lynch SV, et al. Simultaneous quantification of tacrolimus and sirolimus, in human blood, by high-performance liquid chromatography-tandem mass spectrometry[J].Ther Drug Monit,2000, 22(5): 608-612. |